BACKGROUND: This multicenter-based retrospective study aimed to investigate the prognostic factors and report our experiences with the diagnosis and treatment of hepatic epithelioid hemangioendothelioma (HEHE), a rare malignant vascular tumor. METHODS: A total of 33 patients with HEHE from two centers between 2004 and 2011 were retrospectively reviewed with respect to their clinical, radiologic, and pathologic characteristics; treatment modalities and outcomes; and potential prognostic factors. RESULTS: A total of 17 patients underwent liver resections (LRs) alone, 12 patients had transcatheter arterial chemoembolization (TACE) alone, three patients had LR followed by TACE, and one patient underwent liver transplantation (LT). The difference of overall survival (OS) between LR and TACE was not significant (p = 0.499). Older patients [≥47 years, n = 17; p = 0.035, hazard ratio (HR) = 7.0), those with symptoms (n = 17; p = 0.001, HR = 86.5], and those with an elevated serum CA19-9 level (>37 U/ml, n = 5; p = 0.018, HR = 5.0) had a poorer OS, according to univariate analysis. The presence of symptoms was validated as a prognostic factor (p = 0.012) by multivariate analysis. CONCLUSIONS: Liver resection and TACE have comparable outcomes in HEHE patients. The presence of symptoms indicates a poor prognosis. Older age and elevated serum CA19-9 are potential negative impact factors on outcome.
BACKGROUND: This multicenter-based retrospective study aimed to investigate the prognostic factors and report our experiences with the diagnosis and treatment of hepatic epithelioid hemangioendothelioma (HEHE), a rare malignant vascular tumor. METHODS: A total of 33 patients with HEHE from two centers between 2004 and 2011 were retrospectively reviewed with respect to their clinical, radiologic, and pathologic characteristics; treatment modalities and outcomes; and potential prognostic factors. RESULTS: A total of 17 patients underwent liver resections (LRs) alone, 12 patients had transcatheter arterial chemoembolization (TACE) alone, three patients had LR followed by TACE, and one patient underwent liver transplantation (LT). The difference of overall survival (OS) between LR and TACE was not significant (p = 0.499). Older patients [≥47 years, n = 17; p = 0.035, hazard ratio (HR) = 7.0), those with symptoms (n = 17; p = 0.001, HR = 86.5], and those with an elevated serum CA19-9 level (>37 U/ml, n = 5; p = 0.018, HR = 5.0) had a poorer OS, according to univariate analysis. The presence of symptoms was validated as a prognostic factor (p = 0.012) by multivariate analysis. CONCLUSIONS: Liver resection and TACE have comparable outcomes in HEHE patients. The presence of symptoms indicates a poor prognosis. Older age and elevated serum CA19-9 are potential negative impact factors on outcome.
Authors: Arianeb Mehrabi; Arash Kashfi; Hamidreza Fonouni; Peter Schemmer; Bruno M Schmied; Peter Hallscheidt; Peter Schirmacher; Jurgen Weitz; Helmut Friess; Markus W Buchler; Jan Schmidt Journal: Cancer Date: 2006-11-01 Impact factor: 6.860
Authors: F H F Galvão; A Bakonyi-Neto; M A C Machado; A Q Farias; E S Mello; M E Diz; M C C Machado Journal: Transplant Proc Date: 2005-12 Impact factor: 1.066
Authors: D H Dail; A A Liebow; J T Gmelich; P J Friedman; K Miyai; W Myer; S D Patterson; S P Hammar Journal: Cancer Date: 1983-02-01 Impact factor: 6.860
Authors: Jon Cardinal; Michael E de Vera; James W Marsh; Jennifer L Steel; David A Geller; Paulo Fontes; Michael Nalesnik; T Clark Gamblin Journal: Arch Surg Date: 2009-11
Authors: Piotr Remiszewski; Ewa Szczerba; Piotr Kalinowski; Beata Gierej; Krzysztof Dudek; Mariusz Grodzicki; Marcin Kotulski; Rafał Paluszkiewicz; Waldemar Patkowski; Krzysztof Zieniewicz; Marek Krawczyk Journal: World J Gastroenterol Date: 2014-08-28 Impact factor: 5.742
Authors: Ryan M Thomas; Thomas A Aloia; Mark J Truty; Warren H Tseng; Eugene A Choi; Steven A Curley; Jean N Vauthey; Eddie K Abdalla Journal: HPB (Oxford) Date: 2013-12-06 Impact factor: 3.647
Authors: Christina Hackl; Hans J Schlitt; Gabriele I Kirchner; Birgit Knoppke; Martin Loss Journal: World J Gastroenterol Date: 2014-05-14 Impact factor: 5.742
Authors: Mohamad A Chahrour; Hussein H Khachfe; Joseph R Habib; Rudy El-Asmar; Omran Saifi; Faek R Jamali Journal: World J Surg Date: 2021-05-17 Impact factor: 3.352